Lived experiences of survival following cancer treatments

The genomics of cancer in Africa

SABCS 2023: Highlights

The future of Choosing Wisely Africa

Adding nivolumab to R-GemOx shows enhanced efficacy in treating R/R large B-cell lymphoma

BrECADD combined with PET2-guided treatment sets a new benchmark for the treatment of newly diagnosed advanced-stage cHL

SABCS 2023: Latest breast cancer diagnostics guidelines

Introducing oncology to undergraduate medical and allied health sciences students

Low-dose olanzapine after highly emetogenic chemotherapy can be the new standard of care for solid tumours

First-line chemotherapy with atezolizumab and bevacizumab significantly improves survival for R/M cervical cancer

Special issue on real world breast cancer data

Chairperson: Evidence Communication